| AMPK | adenosine monophosphate-activated protein kinase |
| bHLH-PAS | basic helix-loop-helix PER-ARNT-SIM |
| BMAL1/ARNTL | brain and muscle ARNT-like 1/aryl hydrocarbon receptor nuclear translocator like |
| CamK | calcium/calmodulin-dependent protein kinases |
| cAMP | cyclic adenosine monophosphate; |
| CKI | casein kinases |
| CLOCK | clock circadian regulator/circadian locomotor output cycles protein kaput |
| CPAP | continuous positive airway pressure treatment |
| CREB | phosphorylate cAMP-responsive element-binding protein |
| Cry2 | cryptochrome 2 |
| CVD | cardio-vascular disease |
| DBP | albumin d-element binding protein |
| E4BP4 | E4 binding protein 4 |
| E-box | enhancer box; GSK3β—Glycogen synthase kinase 3β |
| HIF | hypoxia inducible factor |
| HMG-CoA | 3-hydroxy-3-methylglutaryl-coenzyme A synthase |
| HRE | hypoxia response element |
| IH | intermittent hypoxia |
| LDHA | lactate dehydrogenase A |
| MAPK | mitogen-activated protein kinases |
| mTOR | mechanistic target of rapamycin kinase |
| NMDAR | N-methyl-d-aspartate receptors |
| NPAS2 | neuronal PAS domain protein 2 |
| OSA | obstructive sleep apnea |
| PACAP | pituitary adenylate cyclase—activating polypeptide |
| PER1 | period protein 1 |
| PER2 | period protein 2 |
| PER3 | period protein 3 |
| PHD3 | prolyl hydroxylase 3 |
| PKA | protein kinase A |
| PP1 | protein phosphatase 1 |
| PP5 | protein phosphatase 5 |
| REV-ERBα | nuclear receptor subfamily 1 group D member 1 |
| ROR | RAR-related orphan receptor |
| RORE | ROR response elements |
| RORα | Nuclear retinoid-related orphan receptors α |
| SCF-Fbxl3 | E3 ubiquitin ligase complex |
| E3 | ubiquitin ligase complex |
| SCN | suprachiasmatic nucleus |
| T2DM | diabetes mellitus type 2 |
| VEGF | vascular endothelial growth factor |